BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16307656)

  • 21. St. John's Wort reduces neuropathic pain through a hypericin-mediated inhibition of the protein kinase Cgamma and epsilon activity.
    Galeotti N; Vivoli E; Bilia AR; Vincieri FF; Ghelardini C
    Biochem Pharmacol; 2010 May; 79(9):1327-36. PubMed ID: 20045676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
    Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
    Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the hypericin and pseudohypericin content of commercially available St John's Wort preparations.
    Draves AH; Walker SE
    Can J Clin Pharmacol; 2003; 10(3):114-8. PubMed ID: 14506510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
    Brattström A
    Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term evaluation of erythema and pigmentation induced by ultraviolet radiations of different wavelengths.
    Suh KS; Roh HJ; Choi SY; Jeon YS; Doh KS; Bae JH; Kim ST
    Skin Res Technol; 2007 May; 13(2):154-61. PubMed ID: 17374056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of narrowband (TL-01) UVB-induced erythemal response at different body sites.
    Leslie KS; Lodge E; Garioch JJ
    Clin Exp Dermatol; 2005 Jul; 30(4):337-9. PubMed ID: 15953061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of St. John's wort extract and single constituents on stress-induced hyperthermia in mice.
    Grundmann O; Kelber O; Butterweck V
    Planta Med; 2006 Dec; 72(15):1366-71. PubMed ID: 17051457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin tolerance of a new bath oil containing St. John's wort extract.
    Reuter J; Huyke C; Scheuvens H; Ploch M; Neumann K; Jakob T; Schempp CM
    Skin Pharmacol Physiol; 2008; 21(6):306-11. PubMed ID: 18667843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J; Kavanagh DJ; Deed G; Bone KM
    Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
    Bell EC; Ravis WR; Lloyd KB; Stokes TJ
    Ann Pharmacother; 2007 Feb; 41(2):229-34. PubMed ID: 17284505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and clinical relevance of the interactions and side effects of Hypericum preparations.
    Schulz V
    Phytomedicine; 2001 Mar; 8(2):152-60. PubMed ID: 11315759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs.
    Butterweck V; Nahrstedt A; Evans J; Hufeisen S; Rauser L; Savage J; Popadak B; Ernsberger P; Roth BL
    Psychopharmacology (Berl); 2002 Jul; 162(2):193-202. PubMed ID: 12110997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of minimal erythema dose with a reflectance melanin meter.
    Damian DL; Halliday GM; Barnetson RS
    Br J Dermatol; 1997 May; 136(5):714-8. PubMed ID: 9205504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. St John's wort and depression: slight efficacy at best, many drug interactions.
    Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanin differentially protects from the initiation and progression of threshold UV-induced erythema depending on UV waveband.
    Phan TA; Halliday GM; Barnetson RS; Damian DL
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):174-80. PubMed ID: 16869864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Objective determination of Fitzpatrick skin type.
    Ravnbak MH
    Dan Med Bull; 2010 Aug; 57(8):B4153. PubMed ID: 20682135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. St John's wort or sertraline? Randomized controlled trial in primary care.
    van Gurp G; Meterissian GB; Haiek LN; McCusker J; Bellavance F
    Can Fam Physician; 2002 May; 48():905-12. PubMed ID: 12053635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of St. John's wort extract and amitriptyline on autonomic responses of blood vessels and sweat glands in healthy volunteers.
    Siepmann M; Kirch W; Krause S; Joraschky P; Mueck-Weymann M
    J Clin Psychopharmacol; 2004 Feb; 24(1):79-82. PubMed ID: 14709951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
    Man I; Dawe RS; Ferguson J; Ibbotson SH
    Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin.
    Boiy A; Roelandts R; van den Oord J; de Witte PA
    Br J Dermatol; 2008 Feb; 158(2):360-9. PubMed ID: 18047507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.